Rottinghaus Scott T. - Chief Medical Officer at ENANTA PHARMACEUTICALS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
ENTA on Nasdaq
All Insider Reports
All Insider Reports

Rottinghaus Scott T. - trading volume in the past year for ENANTA PHARMACEUTICALS INC

Holdings reported by Rottinghaus Scott T. for ENANTA PHARMACEUTICALS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25,254 $359,869 $14.25 12 Feb 2026 Direct
Stock Option (right to buy) 110,000 25 Nov 2025 Direct Common Stock

Transactions reported by Rottinghaus Scott T. for ENANTA PHARMACEUTICALS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.